litigation: search

Salix commences patent infringement litigation against Novel Laboratories

Add our medical news to StumbleUpon - Salix commences patent infringement litigation against Novel Laboratories Add our medical news to Facebook - Salix commences patent infringement litigation against Novel Laboratories

DVD Seminar - Employment Law Litigation Client Case Studies: Walk Through a Recent Client Case & Explain Your Strategies and Analysis

DVD Seminar - Employment Law Litigation Client Case Studies: Walk Through a Recent Client Case & Explain Your Strategies and Analysis

Perrigo Dismissed from Miconazole Patent Litigation

announced today that the Hatch-Waxman litigation relating to Miconazole Nitrate Vaginal Cream and Suppository between Johnson & Johnson and Perrigo has been dismissed. Earlier this year, Perrigo had been sued by Johnson & Johnson's McNeil unit for infringement of a patent related to Perrigo's filing of an ANDA for a generic to Monistat(R) -1 Combination Pack in the United States District Court for the District of New Jersey. Following FDA approval, Perrigo will begin marketing its product under store brand and value brand labels to its customers.

C2 Communications Technologies settles patent infringement litigation against Qwest, Global Crossing, and Level 3 - Update

C2 Communications Technologies settles patent infringement litigation against Qwest, Global Crossing, and Level 3 - Update

Principle of robotic surgery litigation in the United States

McLean TR - After a robotic surgical misadventure in the United States, the subsequent litigation often involves a medical malpractice action against the surgeon and the hospital, and a products liability action against the robotic surgical instrument manufacturer. Accordingly, metadata within the computer may result in hospitals and surgeons shouldering more of the liability for robotic surgical misadventures.

Visa and Cryptography settle litigation

Cryptography Research, Inc. today announced that it has signed a definitive agreement settling its litigation against Visa, Inc. under which Visa will become a licensee of Cryptography Research's patent portfolio covering countermeasures to Differential Power Analysis (DPA).

C2 Communications settles patent litigation

C2 Communications Inc (C2), a subsidiary of C2 Global Technologies Inc (OTCBB:COBT), announced on 26 September that it has settled its patent infringement litigation against Qwest, Global Crossing and Level 3 by entering into a settlement and license agreement, which also includes Sonus Networks as a licensee.

Mylan's Alphapharm wins patent litigation on generic Razadyne tablets

Mylan has announced that its subsidiary Alphapharm has won a favorable decision in patent litigation against it and Barr Laboratories relating to galantamine tablets, USP, the generic version of Ortho-McNeil's Razadyne tablets, 4mg, 8mg and 12mg.

Thomas Mistrial Decision Bolsters RIAA Litigation

For those keeping tabs on the Recording Industry Association of America's 5-year-old litigation campaign, a federal judge's decision late Wednesday declaring a mistrial in the Jammie Thomas case was a significant event.

Barr and BI call a truce in patent litigation

Boehringer Ingelheim and Barr Laboratories have called a truce in their litigation over the former’s restless leg drug Mirapex (pramipexole) and clotbuster Aggrenox (extended release dipyridamole/aspirin), giving the generics firm a green light to market its copycat versions ahead of the products’ patent expirations.

C2 Communications Technologies settles patent infringement litigation against Qwest, Global Crossing, and Level 3 - Update

(RTTNews) - Friday, C2 Communications Technologies Inc., a unit of C2 Global Technologies Inc. (COBT.OB) said it settled its patent infringement litigation against Qwest, Global Crossing, and Level 3 by entering into a Settlement and License Agreement. The Settlement and License Agreement also includes Sonus Networks, Inc. as a licensee. The terms of the agreement were not disclosed.

Universal Avionics Reaches Favorable Settlement in Patent Litigation against Optima Technology Group

TUCSON, Ariz. - Universal Avionics Systems Corporation reached a settlement today with Optima Technology Group, Inc. in its patent litigation before Judge Raner Collins in the District of Arizona. Universal filed the lawsuit on November 9, 2007 against Optima, a patent

Universal Avionics Reaches Favorable Settlement in Patent Litigation against Optima Technology Group

TUCSON, Ariz., BUSINESS WIRE -- Universal Avionics Systems Corporation reached a settlement today with Optima Technology Group, Inc. in its patent litigation before Judge Raner Collins in the District of Arizona.

Universal Avionics Reaches Favorable Settlement in Patent Litigation against Optima Technology Group

TUCSON, Ariz.-- (BUSINESS WIRE) -- Universal Avionics Systems Corporation reached a settlement today with Optima Technology Group, Inc. in its patent litigation before Judge Raner Collins in the District of Arizona.

Wi-LAN, Research In Motion Settle Patent litigation

(RTTNews) - Canada-based technology licensing company Wi-LAN Inc. (WIN.TO: News, Chart, Quote ) Monday said it settled a pending patent litigation against wireless technology company Research In Motion Limited (RIMM: News, Chart, Quote , RIM.TO). Under the settlement, Research In Motion obtained a license to certain patents of Wi-LAN in wireless technology. The company noted that the specific terms of the agreement are confidential.

LendingTree, LLC and IMX, Inc. Announce Settlement of Patent Litigation

EL DORADO HILLS, Calif.--(BUSINESS WIRE)--LendingTree and IMX today announced that they have settled their outstanding patent litigation. The settlement agreement satisfies the judgment entered against LendingTree in favor of IMX, and resolves all claims asserted in the pending appeal of that judgment. As a result of the settlement agreement, the appeal will be dismissed and LendingTree will receive a patent license from IMX.

LendingTree, LLC and IMX, Inc. Announce Settlement of Patent Litigation

EL DORADO HILLS, Calif. (Business Wire) -- LendingTree and IMX today announced that they have settled their outstanding patent litigation. The settlement agreement satisfies the judgment entered against LendingTree in favor of IMX, and resolves all claims asserted in the pending appeal of that judgment. As a result of the settlement agreement, the appeal will be dismissed and LendingTree will receive a patent license from IMX.

24 Sep 08 | US Court Denies Teva?s Motion For Summary Judgment In Pulmicort Respules Patent Litigation

24 Sep 08 | US Court Denies Teva’s Motion For Summary Judgment In Pulmicort Respules Patent Litigation

US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation

has denied Teva's Motion for Summary Judgment of no infringement in the PULMICORT RESPULES(R) (budesonide inhalation suspension) patent litigation.

US court denies Teva's motion for summary judgment in Pulmicort Respules patent litigation

AstraZeneca announced that the US District Court for the District of New Jersey has denied Teva's Motion for Summary Judgment of no infringement in the Pulmicort Respules (budesonide inhalation suspension) patent litigation.

Digital Ally, Inc. and L-3 Communications Mobile-Vision, Inc. Resolve Patent Litigation

PRNewswire-FirstCall/ -- Digital Ally, Inc. (Nasdaq: DGLY), which develops, manufactures and markets advanced video surveillance products for law enforcement, homeland security and commercial security applications, today announced that L-3 Communications Mobile-Vision, Inc. ("Mobile-Vision") and Digital Ally, Inc. ("Digital Ally") have resolved all litigation pertaining to Mobile-Vision's allegations that Digital Ally's current DVM-500 products infringe Mobile-Vision's United States Patent No. 7,119,832. Based on technical disclosures and representations provided by Digital Ally to Mobile-Vision, the parties have agreed that the current DVM-500 products do not infringe Mobile-Vision's '832 patent and that no damages are payable based on those technical disclosures and representations.

US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation

WILMINGTON, Del., Sept. 23 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has denied Teva's Motion for Summary Judgment of no infringement in the PULMICORT RESPULES® (budesonide inhalation suspension) patent litigation.

US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation

WILMINGTON, Del., Sept. 23 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has denied Teva's Motion for Summary Judgment of no infringement in the PULMICORT RESPULES(R) (budesonide inhalation suspension) patent litigation.

US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation

WILMINGTON, Del., Sept. 23 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has denied Teva's Motion for Summary Judgment of no infringement in the PULMICORT RESPULES(R) (budesonide inhalation suspension) patent litigation.

United States Appellate Court Rules in Buffalo's Favor in Ongoing U.S. Patent Litigation

AUSTIN, Texas, Sept. 24, 2008 (GLOBE NEWSWIRE) -- Buffalo Technology, a global leader in the design, development and manufacturing of wired and wireless networking, storage and memory solutions today released a statement, providing an update regarding the status of the ongoing U.S. patent litigation with respect to the offer to sell, use, import or manufacture of Buffalo's IEEE 802.11a and 802.11g standard compliant products in Commonwealth Scientific Research and Industrial Organization v. Buffalo Technology (USA), Inc. and Buffalo, Inc.

Search took 0.02 seconds.